{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:23Z","timestamp":1787261003011,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ctro.2026.101241","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T06:55:59Z","timestamp":1784962559000},"page":"101241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MRI-guided adaptive stereotactic body radiotherapy for the prostate bed: a prospective study of safety, tolerability, and patient-reported quality-of-life outcomes"],"prefix":"10.1016","volume":"60","author":[{"given":"Daniela Gonsalves","family":"Pieretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"L\u00f3pez-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrahams","family":"Ocanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisselott","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Castalia","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Guardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Andreescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Viduera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce","family":"Urias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofelia","family":"Cabanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Rogriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigfredo Elias","family":"Romero Zoghbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Gazta\u00f1aga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Glaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Dzhugashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Arcangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ferrario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio Martinez","family":"Salamanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Francolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Cou\u00f1ago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101241_bb0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101241_bb0010","first-page":"585","article-title":"Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)","volume":"35","author":"Parker","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2026.101241_bb0015","first-page":"3524","article-title":"Hypofractionated vs. conventionally fractionated radiotherapy for prostate cancer after radical prostatectomy (NRG-GU003): a phase III trial","volume":"41","author":"Pisansky","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101241_rf0020","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jamaoncol.2025.1059","article-title":"Patient-reported outcomes with stereotactic intensity modulated radiotherapy after radical prostatectomy: a nonrandomized clinical trial","volume":"11","author":"Nikitas","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ctro.2026.101241_rf0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2025.09.4149","article-title":"Stereotactic intensity-modulated radiotherapy after radical prostatectomy (SCIMITAR): 4-year outcomes of a phase 2 clinical trial","volume":"89","author":"Kishan","year":"2026","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ctro.2026.101241_bb0025","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG oncology\/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101241_bb0030","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1186\/s12885-023-11278-3","article-title":"Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)","volume":"23","author":"Marciscano","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2026.101241_bb0035","first-page":"81","article-title":"Perceptions of patients and healthcare professionals of SBRT for prostate cancer: a qualitative study","volume":"124","author":"Raison","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.ctro.2026.101241_bb0040","first-page":"841","article-title":"Stereotactic body radiotherapy for prostate cancer: a radiobiological and clinical perspective","volume":"127","author":"Annamraju","year":"2022","journal-title":"Radiol Med"},{"key":"10.1016\/j.ctro.2026.101241_bb0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.8006","article-title":"Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer","volume":"2","author":"Kishan","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ctro.2026.101241_bb0050","first-page":"432","article-title":"Magnetic resonance-guided adaptive stereotactic radiotherapy in prostate cancer patients: a systematic literature review","volume":"17","author":"Szablewska","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.ctro.2026.101241_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2026.104074","article-title":"Does overall treatment time impact toxicity and clinical outcomes after MRI-guided stereotactic body radiotherapy to the prostate?","volume":"53","author":"Westley","year":"2026","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101241_bb0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic resonance imaging\u2013guided vs. computed tomography\u2013guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101241_bb0065","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/life14070870","article-title":"Image-guided stereotactic body radiotherapy on detectable prostate bed recurrence after prostatectomy in RT-na\u00efve patients","volume":"14","author":"Santamaria","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.ctro.2026.101241_bb0070","first-page":"1542330","article-title":"Innovative approaches in precision radiation oncology: advanced imaging technologies and challenges which shape the future of radiation therapy","volume":"15","author":"Yan","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101241_bb0075","article-title":"Real-time adaptive motion management in prostate stereotactic body radiation therapy: clinical and dosimetric analysis of 25 patients","volume":"17","author":"Goddard","year":"2025","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ctro.2026.101241_bb0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2026.02.194","article-title":"Outcomes of a phase II interventional clinical trial of prostate bed stereotactic body radiation therapy for prostate cancer with high-risk features following radical prostatectomy","volume":"125","author":"Vargas","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101241_bb0085","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eururo.2019.01.045","article-title":"Androgen deprivation therapy and salvage radiotherapy: are we missing something?","volume":"76","author":"Gonz\u00e1lez-San Segundo","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2026.101241_bb0090","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2017.06.014","article-title":"Elective nodal irradiation in the salvage treatment of prostate cancer: a systematic review","volume":"98","author":"Ramey","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101241_bb0095","first-page":"252","article-title":"Is there a role for pelvic lymph node irradiation in the salvage setting for patients with biochemical recurrence after radical prostatectomy?","volume":"48","author":"Song","year":"2016","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ctro.2026.101241_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2024.07.2325","article-title":"Reduction of postradiation therapy urinary toxicity via intrafractional megavoltage-kilovoltage prostate location monitoring","volume":"121","author":"Zhang","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2026.101241_bb0105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2009.02.006","article-title":"Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101241_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.858740","article-title":"1.5T MR-guided daily adaptive stereotactic body radiotherapy for prostate re-irradiation: a preliminary report of toxicity and clinical outcomes","volume":"12","author":"Cuccia","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2026.101241_bb0115","article-title":"Toxicity profile and patient-reported outcomes following salvage stereotactic ablative radiation therapy to the prostate bed: the POPART multicentric prospective study","volume":"44","author":"Ferrario","year":"2023","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:23:41Z","timestamp":1787257421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"alternative-id":["S2405630826001369"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101241","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI-guided adaptive stereotactic body radiotherapy for the prostate bed: a prospective study of safety, tolerability, and patient-reported quality-of-life outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101241"}}